Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 TrialJ. Clin. Oncol 2019 Mar 12;[EPub Ahead of Print], SA Rosenthal, C Hu, O Sartor, LG Gomella, MB Amin, J Purdy, JM Michalski, MG Garzotto, N Pervez, AG Balogh, GB Rodrigues, L Souhami, MN Reaume, SG Williams, R Hannan, EM Horwitz, A Raben, CA Peters, FY Feng, WU Shipley, HM Sandler
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.